Sierra Li

958 total citations
5 papers, 576 citations indexed

About

Sierra Li is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sierra Li has authored 5 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Sierra Li's work include Renal and related cancers (4 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Cell death mechanisms and regulation (1 paper). Sierra Li is often cited by papers focused on Renal and related cancers (4 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Cell death mechanisms and regulation (1 paper). Sierra Li collaborates with scholars based in United States and Canada. Sierra Li's co-authors include Norman E. Breslow, Patrick R. Thomas, J. Bruce Beckwith, Giulio J. D’Angio, Daniel M. Green, Elizabeth J. Perlman, Gail E. Tomlinson, Paul E. Grundy, Michael L. Ritchey and Gerald M. Haase and has published in prestigious journals such as Journal of Clinical Oncology, JAMA Oncology and Journal of Pediatric Hematology/Oncology.

In The Last Decade

Sierra Li

5 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sierra Li United States	5	492	285	120	104	85	5	576
Mona S. Jahromi United States	10	84 0.2×	78 0.3×	38 0.3×	49 0.5×	40 0.5×	13	259
Mazen A. Ghanem Egypt	11	200 0.4×	140 0.5×	72 0.6×	9 0.1×	48 0.6×	24	375
Albertien M. van Eerde Netherlands	13	256 0.5×	58 0.2×	117 1.0×	38 0.4×	15 0.2×	30	452
Trudie E. Muir United States	6	118 0.2×	197 0.7×	16 0.1×	45 0.4×	61 0.7×	7	307
Zehra Ordulu United States	12	130 0.3×	88 0.3×	91 0.8×	48 0.5×	72 0.8×	36	559
D. Yu. Kachanov Russia	9	60 0.1×	39 0.1×	27 0.2×	31 0.3×	49 0.6×	93	224
Kortnye Smith Australia	7	53 0.1×	56 0.2×	21 0.2×	38 0.4×	95 1.1×	11	210
Kelley V. Foyil United States	10	65 0.1×	93 0.3×	21 0.2×	101 1.0×	101 1.2×	15	293
Ryusuke Watanabe Japan	8	151 0.3×	73 0.3×	9 0.1×	22 0.2×	48 0.6×	21	346
Rabea Wagener Germany	8	64 0.1×	38 0.1×	22 0.2×	66 0.6×	37 0.4×	26	236

Countries citing papers authored by Sierra Li

Since Specialization

Citations

This map shows the geographic impact of Sierra Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sierra Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sierra Li more than expected).

Fields of papers citing papers by Sierra Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sierra Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sierra Li. The network helps show where Sierra Li may publish in the future.

Co-authorship network of co-authors of Sierra Li

This figure shows the co-authorship network connecting the top 25 collaborators of Sierra Li. A scholar is included among the top collaborators of Sierra Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sierra Li. Sierra Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Fakih, Marwan, et al.. (2023). Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy. JAMA Oncology. 9(5). 627–627. 60 indexed citations

2.

Karaçay, Bahri, Norman E. Breslow, Sierra Li, et al.. (2005). Prognostic Value of Quantifying Apoptosis Factor Expression in Favorable Histology Wilms Tumors. Journal of Pediatric Hematology/Oncology. 27(1). 11–14. 8 indexed citations

3.

Grundy, Paul E., Norman E. Breslow, Sierra Li, et al.. (2005). Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group. Journal of Clinical Oncology. 23(29). 7312–7321. 284 indexed citations

4.

Tomlinson, Gail E., Norman E. Breslow, Jeffrey S. Dome, et al.. (2005). Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic Factor. Journal of Clinical Oncology. 23(30). 7641–7645. 150 indexed citations

5.

Seibel, Nita L., Sierra Li, Norman E. Breslow, et al.. (2004). Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms' Tumor Study Group. Journal of Clinical Oncology. 22(3). 468–473. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact